Hepatitis C Medicines
In plain English
The notice doesn't say
Who holds it now
Last won by Amgen Ltd and Fresenius Kabi Ltd and Celltrion Healthcare and 2 more in Aug 2026, for £7.8m.
- UstekinumabAmgen Ltd, Fresenius Kabi Ltd, Celltrion Healthcare and 2 more £7.8m
- Generic Drugs – Injections/Infusions 2Accord UK Ltd, Aspire Pharma Ltd, B Braun Medical Ltd and 13 more £7m
- Transitional Drugs 7Amgen Ltd, Celltrion Healthcare, Fresenius Kabi Ltd and 7 more £20.2m
What you're up against
- The same firms have won it the last 3 times Kestrel found: expect them to bid again, and to know the work well.
- 26 different firms won this buyer's 3 awards for this kind of work in 2026.
- It last went for £7.8m in 2026.
- The last award named 5 suppliers: it may be a framework, where many firms are chosen.
The notice as published
This tender is for the provision of antiviral medicines for the treatment of Hepatitis C (HCV) to NHS Wales.